These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 329806)

  • 1. [Electrocardiographic and hemodynamic disorders induced by verapamil: experimental study].
    Belardinelli L; Sant'Anna JR; Mattos E; Wagner EM; Lucchese FA
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():31-6. PubMed ID: 329806
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of verapamil on electrocardiographic rhythm disorders. Clinical and experimental results].
    Chapelle M; Benaim R; Chiche P; Cabrol C; Cabrol A
    Therapie; 1973; 28(4):689-701. PubMed ID: 4602479
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological aspects and therapeutic uses of verapamil and related calcium antagonists (author's transl)].
    Penna M; Pescio S
    Rev Med Chil; 1980 Oct; 108(10):924-30. PubMed ID: 7012975
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of verapamil on the cycloergometric test in patients of coronary artery disease].
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():71-4. PubMed ID: 329811
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical use of verapamil.
    McGoon MD; Vlietstra RE; Holmes DR; Osborn JE
    Mayo Clin Proc; 1982 Aug; 57(8):495-510. PubMed ID: 7047918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of verapamil on the acute experimental myocardial ischemia.
    Carp C; Pleşea O; Câmpeanu A
    Med Interne; 1980; 18(4):357-70. PubMed ID: 7455581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodynamic evaluation of the action of calcium antagonists].
    Vincenzi M; Allegri P; Barbieri E; Cappelletti F; Carrozza A; De Lio U; Maiolino P; Morlino T; Ometto R
    Boll Soc Ital Cardiol; 1978; (1 Suppl):79-97. PubMed ID: 757682
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of dantrolene and verapamil on atrioventricular conduction and cardiovascular performance in dogs.
    Lynch C; Durbin CG; Fisher NA; Veselis RA; Althaus JS
    Anesth Analg; 1986 Mar; 65(3):252-8. PubMed ID: 3954091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of ischemic heart disease with verapamil].
    Ostapiuk FE; Dobrotvorskaia TE; Khavazha KhA
    Sov Med; 1985; (11):78-81. PubMed ID: 4089643
    [No Abstract]   [Full Text] [Related]  

  • 10. [Calcium-antagonist-type cardiac effects of nifedipine in vitro and in vivo. Comparative experimental study].
    Cosín J; Gimeno JV; Martín G; Ramírez A; Ferrer J; Báguena J
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II115-22. PubMed ID: 7170402
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency].
    Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of verapamil on the dynamics of heart conduction].
    Amino JG; Studart PC; de Brito AH; Brando PR; Maia IG; Almeida G; Dohmann HJ
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():37-41. PubMed ID: 889473
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute hemodynamic effect of verapamil, used intravenously, in patients with primary dilated cardiomyopathy].
    Manfroi WC; Ludwig RT; Vieira SR; Goldim JR; Das SK; de Freitas FM; Faraco EZ
    Arq Bras Cardiol; 1985 Nov; 45(5):371-5. PubMed ID: 3915860
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanisms of verapamil prevention of disorders of cardiac contractile function during ischemia and reperfusion].
    Bratus' VV; Bezus'ko AG; Shabaran SS; Filonenko VV
    Patol Fiziol Eksp Ter; 1989; (5):26-9. PubMed ID: 2616210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic and electrocardiographic effects of verapamil in ischemic cardiopathy].
    Aquaro G; Belli R; Ravera A; Rey L; Possavino G; Trucco G; Pavia M; Idone P
    Boll Soc Ital Cardiol; 1981; 26(12):2143-6. PubMed ID: 7185381
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction in infarct size following experimental coronary occlusion by administration of verapamil.
    Singh BN; Smith HJ; Norris RM
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():435-52. PubMed ID: 813284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac effects of isoproterenol during graded myocardial ischemia.
    Lekven J; Kjekshus JK; Mjös OD
    Scand J Clin Lab Invest; 1974 Apr; 33(2):161-71. PubMed ID: 4850884
    [No Abstract]   [Full Text] [Related]  

  • 18. [Verapamil, its action on the left ventricle].
    Romão N; Santos MA; Moll JN; Soares RV; Barbosa V; Aquino JU; Reis NB
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():43-7. PubMed ID: 329807
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium channel blockers: rationale for their clinical use.
    Conti CR
    J Fla Med Assoc; 1981 Nov; 68(11):883-6. PubMed ID: 6120992
    [No Abstract]   [Full Text] [Related]  

  • 20. [The verapamil correction of postresuscitation damages to the heart].
    Korpacheva OV; Dolgikh VT
    Anesteziol Reanimatol; 1996; (5):48-51. PubMed ID: 9027256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.